Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
NVS-MLLT-1 is an inhibitor of the YEATS domain-containing proteins MLLT1 and MLLT3 (IC50s = 0.15 and 0.254 µM, respectively).1 It is selective for MLLT1 and MLLT3 over the YEATS domain-containing proteins YEATS2 and YEATS4 (IC50s = >20 µM for both), as well as over the cat eye syndrome critical region protein 2 (CECR2) bromodomain (IC50 = >40 µM). NVS-MLLT-1 binds to wild-type MLLT1 (IC50 = 0.18 µM) and MLLT1 containing an in-frame insertion (T1 mutant) or deletion (T2 mutant) mutation (Kds = 0.24 and 0.22 µM, respectively).2 See the Structural Genomics Consortium (SGC) website for more information.
WARNING This product is not for human or veterinary use.
1. NVS-
2. Structure and inhibitor binding characterization of oncogenic MLLT1 mutants. ACS Chem. Biol. 16(4), 571-578 (2021).